Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations

Lignende værker

• Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site
  af: Platz, Anton, et al.
  Udgivet: (2007)
• Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
  af: Spagnolo, Francesco, et al.
  Udgivet: (2021)
• Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status
  af: Das, Ishani, et al.
  Udgivet: (2019)
• Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development
  af: Bruno, William, et al.
  Udgivet: (2017)
• A Novel Flexible Multiplex Bead-based Assay for Detecting Germline CDKN2A and CDK4 Variants in Melanoma-Prone Kindreds
  af: Lang, Julie, et al.
  Udgivet: (2010)